Реестр международных мультицентровых клинических исследований лекарств в Украине

Última atualização: Agosto 17, 2026

Study List:

Estudar 1:
Título: Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Thyroid Cancer|Thyroid Disease
Interventions:
URL: http://ClinicalTrials.gov/show/NCT00341094

Estudar 2:
Título: Methadone Maintenance & HIV Risk in Ukraine
Recruitment: Recruiting
Study Results: No Results Available
Condições: Opioid Dependence
Interventions: Medicamento: Methadone
URL: http://ClinicalTrials.gov/show/NCT00351026

Estudar 3:
Título: Peer Leaders as HIV Risk Reduction Change Agents Among Injection Drug Users (IDUs) in Ukraine
Recruitment: Not yet recruiting
Study Results: No Results Available
Condições: HIV Infections|Intervention
Interventions: Behavioral: Peer Education Model|Behavioral: HIV Counseling and Education Model
URL: http://ClinicalTrials.gov/show/NCT01159704

Estudar 4:
Título: Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident
Recruitment: Completed
Study Results: No Results Available
Condições: Leucemia
Interventions: Behavioral: Occupational Radiation Safety Standards
URL: http://ClinicalTrials.gov/show/NCT00341016

Estudar 5:
Título: Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, Tracheobronchitis and Bronchitis, Acute Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in Ukraine
Recruitment: Completed
Study Results: Has Results
Condições: Respiratory Tract Infections
Interventions: Medicamento: Claritromicina (Klacid SR)
URL: http://ClinicalTrials.gov/show/NCT01095978

Estudar 6:
Título: Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Studyy
Recruitment: Completed
Study Results: No Results Available
Condições: Thyroid Cancer
Interventions:
URL: http://ClinicalTrials.gov/show/NCT01265381

Estudar 7:
Título: Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
Recruitment: Completed
Study Results: No Results Available
Condições: Advanced Prostate Cancer|Lower Urinary Tract Symptoms
Interventions: Medicamento: Leuprolide acetate Depot Susp. 11,25 mg (Polônia), 3,75 mg (Ucrânia)
URL: http://ClinicalTrials.gov/show/NCT01078545

Estudar 8:
Título: International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks
Recruitment: Recruiting
Study Results: No Results Available
Condições: Ambiente
Interventions:
URL: http://ClinicalTrials.gov/show/NCT00339274

Estudar 9:
Título: Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical Practice
Recruitment: Recruiting
Study Results: No Results Available
Condições: General Surgery
Interventions: Medicamento: sevoflurane
URL: http://ClinicalTrials.gov/show/NCT01282086

Estudar 10:
Título: Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV
Recruitment: Enrolling by invitation
Study Results: No Results Available
Condições: TB|HIV
Interventions: Dietary Supplement: Immunoxel|Medicamento: Placebo|Medicamento: TB drugs+ Immunoxel|Medicamento: ATT+Placebo|Medicamento: ATT + Placebo|Medicamento: drug-resistant TB on ATT+Immunoxel|Medicamento: Immunoxel
URL: http://ClinicalTrials.gov/show/NCT01061593

Estudar 11:
Título: Phase II Trial Comparing ABI-007 to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Metastatic Breast Cancer
Interventions: Medicamento: Araxane versus Taxotere
URL: http://ClinicalTrials.gov/show/NCT00274456

Estudar 12:
Título: Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma
Recruitment: Completed
Study Results: No Results Available
Condições: Bronchial Asthma
Interventions: Medicamento: salbutamol 100 mcg|Medicamento: BDP/salbutamol HFA pMDI|Medicamento: BDP/salbutamol CFC pMDI
URL: http://ClinicalTrials.gov/show/NCT00528723

Estudar 13:
Título: Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
Recruitment: Completed
Study Results: Has Results
Condições: Bacterial Infections|Diabetic Foot|Osteomielite
Interventions: Medicamento: Tigecycline|Medicamento: Ertapenem
URL: http://ClinicalTrials.gov/show/NCT00366249

Estudar 14:
Título: Study Evaluating PPM-204 In Subjects With Type 2 Diabetes
Recruitment: Terminated
Study Results: No Results Available
Condições: Diabetes Mellitus
Interventions: Medicamento: PPM-204
URL: http://ClinicalTrials.gov/show/NCT00425919

Estudar 15:
Título: Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause
Recruitment: Completed
Study Results: No Results Available
Condições: Menopausa
Interventions: Medicamento: DVS-233
URL: http://ClinicalTrials.gov/show/NCT00195546

Estudar 16:
Título: Tuberculose (TB) Immunotherapy Phase 2 Estudar
Recruitment: Recruiting
Study Results: No Results Available
Condições: Tuberculose
Interventions: Biological: V7|Outro: placebo
URL: http://ClinicalTrials.gov/show/NCT01380119

Estudar 17:
Título: Russian Labor Migrant HIV Prevention Trial
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: HIV
Interventions: Behavioral: Social Network Intervention
URL: http://ClinicalTrials.gov/show/NCT01177995

Estudar 18:
Título: Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC
Recruitment: Not yet recruiting
Study Results: No Results Available
Condições: Metastatic Colorectal Cancer
Interventions: Medicamento: Irintoecan|Medicamento: HA-Irinotecan solution for Infusion
URL: http://ClinicalTrials.gov/show/NCT01290783

Estudar 19:
Título: Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Recruitment: Recruiting
Study Results: No Results Available
Condições: Esclerose múltipla
Interventions: Medicamento: Teriflunomide (HMR1726)|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT00622700

Estudar 20:
Título: Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Recruitment: Completed
Study Results: Has Results
Condições: Fibrilação atrial|AVC
Interventions: Medicamento: warfarin|Medicamento: Dabigatran dose 1|Medicamento: Dabigatran dose 2
URL: http://ClinicalTrials.gov/show/NCT00262600

Estudar 21:
Título: 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Pulmonary Disease, Chronic Obstructive|Bronquite Crônica|Enfisema
Interventions: Medicamento: GSK573719/GW642444 125/25|Medicamento: GSK573719/GW642444 62.5/25|Medicamento: GW642444|Medicamento: tiotropium bromide
URL: http://ClinicalTrials.gov/show/NCT01316900

Estudar 22:
Título: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Recruitment: Recruiting
Study Results: No Results Available
Condições: Venous Thrombosis
Interventions: Medicamento: Enoxaparin|Medicamento: warfarin|Medicamento: Placebo for apixaban|Medicamento: Placebo for enoxaparin|Medicamento: Placebo for warfarin|Medicamento: apixaban
URL: http://ClinicalTrials.gov/show/NCT00643201

Estudar 23:
Título: LOGiC – Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Recruitment: Recruiting
Study Results: No Results Available
Condições: or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.|ErbB2 (HER2) Amplified Gastric|Neoplasms, Gastrointestinal Tract|Esophageal
Interventions: Medicamento: Lapatinib|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT00680901

Estudar 24:
Título: A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Recruitment: Recruiting
Study Results: No Results Available
Condições: Major Depressive Disorder
Interventions: Medicamento: LY2216684|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT01173601

Estudar 25:
Título: Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (IG) Safety In High GI Risk Patients With Arthritis
Recruitment: Completed
Study Results: Has Results
Condições: Osteoartrite|Artrite, Rheumatoid
Interventions: Medicamento: Celecoxibe|Medicamento: Diclofenaco + Omeprazole
URL: http://ClinicalTrials.gov/show/NCT00141102

Estudar 26:
Título: Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
Recruitment: Completed
Study Results: No Results Available
Condições: Venous Thrombosis|Embolia Pulmonar
Interventions: Medicamento: Apixaban|Medicamento: Enoxaparin
URL: http://ClinicalTrials.gov/show/NCT00457002

Estudar 27:
Título: EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Artrite reumatoide|Artrite Psoriática|Espondilite anquilosante
Interventions:
URL: http://ClinicalTrials.gov/show/NCT01078402

Estudar 28:
Título: The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: CV Risk|Aterosclerose|Doença Cardiovascular|Coronary Heart Disease
Interventions: Medicamento: Darapladib|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT00799903

Estudar 29:
Título: Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Recruitment: Completed
Study Results: Has Results
Condições: Bacterial Pneumonia
Interventions: Medicamento: Ceftaroline fosamil for Injection|Medicamento: IV Ceftriaxone|Medicamento: Placebo|Medicamento: Claritromicina
URL: http://ClinicalTrials.gov/show/NCT00621504

Estudar 30:
Título: A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
Recruitment: Completed
Study Results: No Results Available
Condições: Diabetes Mellitus, Tipo 2
Interventions: Medicamento: aleglitazar|Medicamento: Actos
URL: http://ClinicalTrials.gov/show/NCT00461006

Estudar 31:
Título: Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia
Recruitment: Completed
Study Results: No Results Available
Condições: Esquizofrenia
Interventions: Medicamento: Placebo|Medicamento: RGH-188|Medicamento: RGH-188|Medicamento: RGH-188|Medicamento: Risperidona
URL: http://ClinicalTrials.gov/show/NCT00694707

Estudar 32:
Título: Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Recruitment: Recruiting
Study Results: No Results Available
Condições: Diabetes Mellitus, Tipo 2|Acute Coronary Syndrome
Interventions: Medicamento: Alogliptin|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT00968708

Estudar 33:
Título: Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Metastatic Colorectal Cancer
Interventions: Medicamento: Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)|Medicamento: Matching placebo + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)
URL: http://ClinicalTrials.gov/show/NCT00865709

Estudar 34:
Título: Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
Recruitment: Completed
Study Results: No Results Available
Condições: Refractory Partial Seizures
Interventions: Medicamento: perampanel|Medicamento: perampanel|Medicamento: perampanel|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT00700310

Estudar 35:
Título: BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Esclerose múltipla
Interventions: Medicamento: laquinimod|Medicamento: placebo|Medicamento: Interferon β-1a (Avonex®)
URL: http://ClinicalTrials.gov/show/NCT00605215

Estudar 36:
Título: Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Recruitment: Recruiting
Study Results: No Results Available
Condições: Artrite, Rheumatoid|Osteoartrite
Interventions: Medicamento: celecoxib|Medicamento: Ibuprofeno|Medicamento: Naproxen
URL: http://ClinicalTrials.gov/show/NCT00346216

Estudar 37:
Título: Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Recruitment: Terminated
Study Results: No Results Available
Condições: Fibrilação atrial
Interventions: Medicamento: SSR126517E “biotinylated idraparinux”|Medicamento: warfarin
URL: http://ClinicalTrials.gov/show/NCT00580216

Estudar 38:
Título: A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005
Recruitment: Completed
Study Results: No Results Available
Condições: Asma
Interventions: Medicamento: SKP FlutiForm HFA pMDI
URL: http://ClinicalTrials.gov/show/NCT00747318

Estudar 39:
Título: A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Recruitment: Enrolling by invitation
Study Results: No Results Available
Condições: Relapsing Multiple Sclerosis
Interventions: Medicamento: Laquinimod
URL: http://ClinicalTrials.gov/show/NCT01047319

Estudar 40:
Título: Safety and Efficacy Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Esclerose múltipla, Relapsing-remitting
Interventions: Medicamento: daclizumab HYP|Outro: placebo
URL: http://ClinicalTrials.gov/show/NCT00390221

Estudar 41:
Título: A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (EMRR) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injeção 40 mg Administered Three Times a Week Compared to Placebo
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Relapsing Remitting Multiple Sclerosis
Interventions: Medicamento: Glatiramer acetate (GA)|Outro: Placebo
URL: http://ClinicalTrials.gov/show/NCT01067521

Estudar 42:
Título: TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
Recruitment: Completed
Study Results: No Results Available
Condições: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Medicamento: TR-701 FA|Medicamento: Linezolid
URL: http://ClinicalTrials.gov/show/NCT01170221

Estudar 43:
Título: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
Recruitment: Completed
Study Results: No Results Available
Condições: Fibrilação atrial|Atrial Flutter
Interventions: Medicamento: Tedisamil sesquifumarate
URL: http://ClinicalTrials.gov/show/NCT00126022

Estudar 44:
Título: Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms
Recruitment: Completed
Study Results: No Results Available
Condições: Bronchial Asthma
Interventions: Medicamento: Beclomethasone dipropionate|Medicamento: Beclomethasone dipropionate/Salbutamol combination|Medicamento: Salbutamol
URL: http://ClinicalTrials.gov/show/NCT00497523

Estudar 45:
Título: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
Recruitment: Recruiting
Study Results: No Results Available
Condições: Tumor Antigen-positive Non-Small Cell Lung Cancer|Câncer de Pulmão, Non-Small Cell
Interventions: Biological: GSK1572932A Antigen-Specific Cancer Immunotherapeutic|Biological: Placebo Control
URL: http://ClinicalTrials.gov/show/NCT00480025

Estudar 46:
Título: A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
Recruitment: Completed
Study Results: No Results Available
Condições: Asma
Interventions: Medicamento: FlutiForm 250/10|Medicamento: SKP-Fluticasone|Medicamento: Flovent Fluticasone HFA
URL: http://ClinicalTrials.gov/show/NCT00649025

Estudar 47:
Título: FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
Recruitment: Completed
Study Results: No Results Available
Condições: Acute Coronary Syndrome
Interventions: Medicamento: Varespladib Methyl (UM-002)
URL: http://ClinicalTrials.gov/show/NCT00743925

Estudar 48:
Título: A Double-blind, Placebo-controlled, 2-year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer’s Disease.
Recruitment: Recruiting
Study Results: No Results Available
Condições: Alzheimer Disease|Demência, Alzheimer Type
Interventions: Medicamento: Galantamine|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT00679627

Estudar 49:
Título: The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Aterosclerose|Acute Coronary Syndrome|Doença Cardiovascular|Coronary Heart Disease
Interventions: Medicamento: Darapladib 160 mg|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT01000727

Estudar 50:
Título: Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
Recruitment: Recruiting
Study Results: No Results Available
Condições: Adolescent Schizophrenia|Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Interventions: Medicamento: Aripiprazol
URL: http://ClinicalTrials.gov/show/NCT01122927

Estudar 51:
Título: PALMFlexS: Paliperidone Palmitate Flexible Dosing in Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Condições: Esquizofrenia
Interventions: Medicamento: Paliperidone Palmitate
URL: http://ClinicalTrials.gov/show/NCT01281527

Estudar 52:
Título: MICHELANGELO OASIS-6 : Fondaparinux in ST Elevation Myocardial Infarction
Recruitment: Completed
Study Results: No Results Available
Condições: Infarto do Miocárdio|ST-elevation Myocardial Infarction|Acute Coronary Syndrome|Acute Myocardial Infarction
Interventions: Medicamento: Fondaparinux – UFH indicated|Outro: Control – UFH not indicated|Medicamento: fondaparinux – UFH not indicated|Medicamento: Control – UFH
URL: http://ClinicalTrials.gov/show/NCT00064428

Estudar 53:
Título: Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
Recruitment: Completed
Study Results: No Results Available
Condições: Dyslipidemia/Glucose Metabolism Disorder
Interventions: Medicamento: fenofibrate and metformin combination (medicamento)
URL: http://ClinicalTrials.gov/show/NCT00349128

Estudar 54:
Título: A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
Recruitment: Completed
Study Results: No Results Available
Condições: Fibrilação atrial
Interventions: Medicamento: YM150|Medicamento: Warfarin
URL: http://ClinicalTrials.gov/show/NCT00938730

Estudar 55:
Título: Study of Paclitaxel in Patients With Ovarian Cancer
Recruitment: Recruiting
Study Results: No Results Available
Condições: Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer
Interventions: Medicamento: Paclical®|Medicamento: Taxol®
URL: http://ClinicalTrials.gov/show/NCT00989131

Estudar 56:
Título: Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
Recruitment: Completed
Study Results: No Results Available
Condições: Hyperlipidemia
Interventions: Medicamento: fenofibrate / simvastatin|Medicamento: Atorvastatin
URL: http://ClinicalTrials.gov/show/NCT00362934

Estudar 57:
Título: Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
Recruitment: Completed
Study Results: No Results Available
Condições: Fibrilação atrial
Interventions: Medicamento: Placebo|Medicamento: Vernakalant (oral)
URL: http://ClinicalTrials.gov/show/NCT00526136

Estudar 58:
Título: Safety of Inhaled Insulin With Type 1 e tipo 2 Diabetes
Recruitment: Completed
Study Results: No Results Available
Condições: Diabetes, Type I|Diabetes Type 2
Interventions: Medicamento: Technosphere Insulin|Medicamento: Usual Care|Outro: No Intervention
URL: http://ClinicalTrials.gov/show/NCT00308737

Estudar 59:
Título: Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
Recruitment: Completed
Study Results: No Results Available
Condições: Asma
Interventions: Medicamento: Beclomethasone plus formoterol fixed combination|Medicamento: Fluticasone plus salmeterol fixed combination
URL: http://ClinicalTrials.gov/show/NCT00497237

Estudar 60:
Título: Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Pulmonary Disease, Chronic Obstructive
Interventions: Medicamento: tiotropium 2.5 mcg|Medicamento: tiotropium 5 mcg|Medicamento: Tiotropium 18 mcg
URL: http://ClinicalTrials.gov/show/NCT01126437

Estudar 61:
Título: Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
Recruitment: Completed
Study Results: Has Results
Condições: Essential Hypertension
Interventions: Medicamento: Olmesartan medoxomil 40 mg – Amlodipina 10 mg|Medicamento: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg|Medicamento: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg|Medicamento: OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg|Medicamento: OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg|Medicamento: OLM 40mg-AML 10mg-Hydrochlorothiazide 25mg
URL: http://ClinicalTrials.gov/show/NCT00902538

Estudar 62:
Título: Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Recruitment: Recruiting
Study Results: No Results Available
Condições: Tipo 2 Diabetes Mellitus
Interventions: Medicamento: Exenatide Once Weekly|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT01144338

Estudar 63:
Título: Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
Recruitment: Completed
Study Results: No Results Available
Condições: Asma
Interventions: Medicamento: Fluticasone furoate/Vilanterol Inhalation Powder|Medicamento: Fluticasone Furoate Inhalation Powder|Medicamento: Placebo Inhaltion Powder
URL: http://ClinicalTrials.gov/show/NCT01165138

Estudar 64:
Título: Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
Recruitment: Completed
Study Results: Has Results
Condições: Diabetes Mellitus, Tipo 2
Interventions: Medicamento: linagliptin|Medicamento: placebo
URL: http://ClinicalTrials.gov/show/NCT00621140

Estudar 65:
Título: Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Esclerose múltipla, Relapsing-Remitting
Interventions: Medicamento: Daclizumab HYP|Medicamento: Daclizumab HYP
URL: http://ClinicalTrials.gov/show/NCT00870740

Estudar 66:
Título: Phase III Acute Coronary Syndrome
Recruitment: Terminated
Study Results: No Results Available
Condições: Acute Coronary Syndrome
Interventions: Medicamento: Apixaban|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT00831441

Estudar 67:
Título: The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Recruitment: Terminated
Study Results: No Results Available
Condições: Breast Neoplasms|Neoplasms, Hormone-Dependent
Interventions: Medicamento: Atamestane|Medicamento: Toremifene|Medicamento: Letrozol|Medicamento: Aromatase inhibition|Medicamento: Estrogen receptor blocker|Procedimento: Hormone therapy|Procedimento: Endocrine therapy|Procedimento: Antiestrogen therapy
URL: http://ClinicalTrials.gov/show/NCT00097344

Estudar 68:
Título: Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
Recruitment: Completed
Study Results: No Results Available
Condições: Asma
Interventions: Medicamento: Fluticasone Propionate 100mcg BD|Medicamento: GSK2190915 100mg|Medicamento: GSK2190915 10mg|Medicamento: GSK2190915 300mg|Medicamento: GSK2190915 30mg|Medicamento: Montelukast 10mg|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT01147744

Estudar 69:
Título: Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin’s Lymphoma
Recruitment: Completed
Study Results: Has Results
Condições: Non-Hodgkin’s Lymphoma
Interventions: Medicamento: Bortezomib + Rituximab|Medicamento: Rituximab
URL: http://ClinicalTrials.gov/show/NCT00312845

Estudar 70:
Título: TroVax Renal Immunotherapy Survival Trial
Recruitment: Completed
Study Results: No Results Available
Condições: Clear Cell Renal Carcinoma
Interventions: Biological: Trovax
URL: http://ClinicalTrials.gov/show/NCT00397345

Estudar 71:
Título: PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
Recruitment: Completed
Study Results: No Results Available
Condições: Coronary Artery Disease (CAD)
Interventions: Medicamento: UM-002
URL: http://ClinicalTrials.gov/show/NCT00455546

Estudar 72:
Título: VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
Recruitment: Recruiting
Study Results: No Results Available
Condições: Acute Coronary Syndrome
Interventions: Medicamento: UM-002, varespladib methyl|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT01130246

Estudar 73:
Título: Eslicarbazepine Acetate Monotherapy Long Term Study
Recruitment: Recruiting
Study Results: No Results Available
Condições: Epilepsia
Interventions: Medicamento: Eslicarbazepine acetate
URL: http://ClinicalTrials.gov/show/NCT00910247

Estudar 74:
Título: Effectiveness and Safety of Flexible Doses of Paliperidone Prolonged Release in Adolescent Patients With Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Condições: Esquizofrenia
Interventions: Medicamento: Aripiprazol|Medicamento: Paliperidone PR
URL: http://ClinicalTrials.gov/show/NCT01009047

Estudar 75:
Título: Venous Thromboembolic Event (TEV) Prophylaxis in Medically Ill Patients
Recruitment: Completed
Study Results: No Results Available
Condições: Venous Thromboembolism
Interventions: Medicamento: Xarelto (Rivaroxaban, BAY59-7939)|Medicamento: Enoxaparin
URL: http://ClinicalTrials.gov/show/NCT00571649

Estudar 76:
Título: Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
Recruitment: Recruiting
Study Results: No Results Available
Condições: Câncer de pâncreas metastático
Interventions: Medicamento: Albumin-bound paclitaxel (ABI-007)/Gemcitabine|Medicamento: Gemcitabine
URL: http://ClinicalTrials.gov/show/NCT00844649

Estudar 77:
Título: Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing Remitting Multiple Sclerosis
Recruitment: Recruiting
Study Results: No Results Available
Condições: Esclerose múltipla, Relapsing-Remitting
Interventions: Medicamento: Daclizumab HYP
URL: http://ClinicalTrials.gov/show/NCT01051349

Estudar 78:
Título: GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis
Recruitment: Completed
Study Results: No Results Available
Condições: Artrite reumatoide
Interventions: Medicamento: GLPG0259 oral capsule|Medicamento: Placebo|Medicamento: GLPG0259 (Part B)|Medicamento: Placebo (Part B)
URL: http://ClinicalTrials.gov/show/NCT01211249

Estudar 79:
Título: A Study of First-line Maintenance Tarceva (Erlotinib) Versus Tarceva at Time of Disease Progression in Patients With Advanced Non-small Cell Lung Cancer After Chemotherapy
Recruitment: Recruiting
Study Results: No Results Available
Condições: Non-Small Cell Lung Cancer
Interventions: Medicamento: erlotinib [Tarceva]|Medicamento: Placebo|Medicamento: erlotinib [Tarceva]
URL: http://ClinicalTrials.gov/show/NCT01328951

Estudar 80:
Título: Comparison of Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period
Recruitment: Recruiting
Study Results: No Results Available
Condições: Tipo 1 Diabetes Mellitus
Interventions: Medicamento: Technosphere® Insulin with Gen2 Inhaler|Medicamento: Insulin aspart, basal insulin|Medicamento: Technosphere® Insulin with MedTone C Inhaler
URL: http://ClinicalTrials.gov/show/NCT01445951

Estudar 81:
Título: Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV
Recruitment: Recruiting
Study Results: No Results Available
Condições: Peripheral Arterial Occlusive Disease
Interventions: Medicamento: Alprostadil|Outro: Placebo
URL: http://ClinicalTrials.gov/show/NCT00596752

Estudar 82:
Título: 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
Recruitment: Completed
Study Results: Has Results
Condições: Hipertensão
Interventions: Medicamento: fixed-dose combination of telmisartan 40mg+amlodipine 10mg|Medicamento: fixed-dose combination of telmisartan 80mg+amlodipine10mg
URL: http://ClinicalTrials.gov/show/NCT00624052

Estudar 83:
Título: The Purpose of the Study is to Determine Whether Cariprazine is a Safe and Tolerated Long-term Treatment in Patients With Chronic Stable Schizophrenia
Recruitment: Completed
Study Results: No Results Available
Condições: Esquizofrenia
Interventions: Medicamento: Cariprazine
URL: http://ClinicalTrials.gov/show/NCT00839852

Estudar 84:
Título: Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
Recruitment: Completed
Study Results: Has Results
Condições: Thrombosis, Venous|Superficial Thrombophlebitis
Interventions: Medicamento: Fondaparinux 2.5mg or placebo
URL: http://ClinicalTrials.gov/show/NCT00443053

Estudar 85:
Título: A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
Recruitment: Recruiting
Study Results: No Results Available
Condições: Schizoaffective Disorder
Interventions: Medicamento: Placebo|Medicamento: paliperidone palmitate
URL: http://ClinicalTrials.gov/show/NCT01193153

Estudar 86:
Título: A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation
Recruitment: Completed
Study Results: No Results Available
Condições: Fibrilação atrial|Thromboembolism
Interventions: Medicamento: Edoxaban (DU-176b)|Medicamento: Edoxaban (DU-176b)|Medicamento: Edoxaban (DU-176b)|Medicamento: Edoxaban (DU-176b)|Medicamento: warfarin
URL: http://ClinicalTrials.gov/show/NCT00504556

Estudar 87:
Título: Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa
Recruitment: Completed
Study Results: No Results Available
Condições: Acne Vulgaris
Interventions: Medicamento: Valette|Medicamento: Diane|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT00280657

Estudar 88:
Título: Lurasidone – A 24-week Extension Study of Patients With Bipolar I Depression
Recruitment: Recruiting
Study Results: No Results Available
Condições: Bipolar|Depressão
Interventions: Medicamento: lurasidone
URL: http://ClinicalTrials.gov/show/NCT00868959

Estudar 89:
Título: PRoFESS – Prevention Regimen For Effectively Avoiding Second Strokes
Recruitment: Completed
Study Results: Has Results
Condições: Cerebrovascular Accident
Interventions: Medicamento: extended-release dipyridamole + aspirin|Medicamento: clopidogrel|Medicamento: telmisartan
URL: http://ClinicalTrials.gov/show/NCT00153062

Estudar 90:
Título: Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension
Recruitment: Completed
Study Results: Has Results
Condições: Hipertensão
Interventions: Medicamento: amlodipine|Medicamento: telmisartan|Medicamento: telmisartan and amlodipine
URL: http://ClinicalTrials.gov/show/NCT00860262

Estudar 91:
Título: Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Recruitment: Recruiting
Study Results: No Results Available
Condições: Epilepsia
Interventions: Medicamento: Eslicarbazepine acetate 1600 mg|Medicamento: Eslicarbazepine acetate 1200 mg
URL: http://ClinicalTrials.gov/show/NCT01091662

Estudar 92:
Título: Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Ataque cardíaco, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Recruitment: Recruiting
Study Results: No Results Available
Condições: Infarto do Miocárdio|Cardiovascular Death|Atherothrombosis|AVC
Interventions: Medicamento: Ticagrelor 90 mg|Medicamento: Ticagrelor 60 mg|Medicamento: Ticagrelor Placebo
URL: http://ClinicalTrials.gov/show/NCT01225562

Estudar 93:
Título: Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Multiple Myeloma
Interventions: Medicamento: Thalidomide and Dexamethasone|Medicamento: Dexametasona
URL: http://ClinicalTrials.gov/show/NCT00057564

Estudar 94:
Título: Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia
Recruitment: Recruiting
Study Results: No Results Available
Condições: Leukaemia, Lymphocytic, Chronic|Chronic Lymphocytic Leukemia
Interventions: Medicamento: OFC Infusion|Medicamento: FC infusion
URL: http://ClinicalTrials.gov/show/NCT00824265

Estudar 95:
Título: A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
Recruitment: Completed
Study Results: No Results Available
Condições: Fibrose cística
Interventions: Medicamento: tobramycin|Medicamento: tobramycin
URL: http://ClinicalTrials.gov/show/NCT00885365

Estudar 96:
Título: Safety and Efficacy of Cariprazine in Patients With Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Condições: Esquizofrenia
Interventions: Medicamento: Cariprazine|Medicamento: Cariprazine|Medicamento: Aripiprazol|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT01104766

Estudar 97:
Título: Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
Recruitment: Completed
Study Results: Has Results
Condições: Hipertensão
Interventions: Medicamento: fixed dose combination of telmisartan+amlodipine|Medicamento: amlodipine
URL: http://ClinicalTrials.gov/show/NCT00553267

Estudar 98:
Título: Fenofibrate and Metformin Fixed Combination vs Rosiglitazone – FAME ROSI
Recruitment: Terminated
Study Results: No Results Available
Condições: Dyslipidemia|Glucose Metabolism Disorder
Interventions: Medicamento: fenofibrate (F) + metformin (M) hydrochloride fixed combination|Medicamento: Rosiglitazone
URL: http://ClinicalTrials.gov/show/NCT00361868

Estudar 99:
Título: Safety and Efficacy of Cariprazine for Bipolar I Disorder
Recruitment: Recruiting
Study Results: No Results Available
Condições: Mania|Bipolar I Disorder
Interventions: Medicamento: Cariprazine low dose|Medicamento: Cariprazine high dose|Medicamento: Placebo
URL: http://ClinicalTrials.gov/show/NCT01058668

Estudar 100:
Título: A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Recruitment: Ativo, not recruiting
Study Results: No Results Available
Condições: Fibrilação atrial
Interventions: Medicamento: Apixaban|Medicamento: Acetylsalicylic Acid (ASA)|Medicamento: Apixaban
URL: http://ClinicalTrials.gov/show/NCT00496769